Great Finish for the week!
Updated Version including all partners, Based on comprehensive analysis of the UK Automotive Transformation Grants scheme documentation and the established partnerships, here's how Ford, LCM, and EMR qualify for funding and what partnership options are available for IXR's commercial plant.
1. https://find-and-update.company-information.service.gov.uk/company/04850367
2. https://lesscommonmetals.com/uk-government-support-to-research-into-a-facility-for-critical-permanent-magnets/
3. https://www.alcircle.com/news/emrs-low-carbon-aluminium-project-secures-3-4m-in-funding-from-apc-112588
4. https://assets.publishing.service.gov.uk/media/685a9b3872588f4188620741/_Report_on_the_proposed_Automotive_Transformation_Grants_scheme.pdf
Ford, LCM, and EMR all qualify for UK Automotive Transformation Grants and can pursue multiple strategic pathways to support IXR's commercial plant development. The scheme's explicit allowance for consortium applications, combined with comprehensive monitoring frameworks, creates compelling opportunities for integrated supply chain funding while ensuring compliance with policy objectives and prevention of market distortions.
The optimal approach would be a coordinated consortium application that demonstrates complete ZEV supply chain integration, addressing the scheme's primary policy objective of resolving coordination failures while maximizing funding potential across all partners. This approach aligns with the scheme's strategic goals while providing the commercial certainty necessary to convert existing MOUs into binding agreements.
- Forums
- ASX - By Stock
- IXR
- General Chat / Discussion
IXR
ionic rare earths limited
Add to My Watchlist
20.0%
!
1.2¢

General Chat / Discussion, page-14316
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $63.20M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $145.5K | 12.20M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 4930184 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 8157196 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4630184 | 0.011 |
43 | 27026805 | 0.010 |
22 | 15815440 | 0.009 |
22 | 18836661 | 0.008 |
38 | 17744022 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 7757196 | 12 |
0.014 | 9849627 | 14 |
0.015 | 5392525 | 7 |
0.016 | 3379515 | 5 |
0.017 | 3090509 | 6 |
Last trade - 15.58pm 27/06/2025 (20 minute delay) ? |
Featured News
IXR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online